Sutro Biopharma, Inc. Soared
Sutro Biopharma, Inc. (STRO:NASDAQ) shot up at $1.3, representing a gain of 44.4%. On Thu, Apr 24, 2025, STRO:NASDAQ hit a New 2-Week High of $1.3. The stock got featured on our News Catalysts scanner on Fri, Apr 18, 2025 at 03:13 AM in the 'BIOTECH' category. From Thu, Apr 10, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
About Sutro Biopharma, Inc. (STRO:NASDAQ)
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Top 10 Gainers:
- Smart for Life Inc. (SMFL:NASDAQ), 150%
- Odyssey Marine Exploration, Inc. (OMEX:NASDAQ), 100.07%
- Cantor Equity Partners Inc. (CEP:NASDAQ), 50.3%
- TMC the metals company Inc. (TMC:NASDAQ), 44.71%
- Sutro Biopharma, Inc. (STRO:NASDAQ), 44.44%
- Pony AI Inc. (PONY:NASDAQ), 39.41%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 38.85%
- Wag! Group Co. (PET:NASDAQ), 38.26%
- The Arena Group Holdings Inc. (AREN:NYSEMKT), 36.31%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 34.91%